The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives.
Interest in the biology of white adipose tissue has increased dramatically since the discovery of leptin in 1994. The identification of the product of the gene obese (ob) threw light on the role of adipose tissue in the physiopathology of obesity-related diseases and spurred the identification of numerous other adipokines, many of a proinflammatory nature. It has become increasingly evident that white adipose tissue-derived cytokines mediate between obesity-related exogenous factors (nutrition and lifestyle) and the molecular events that lead to metabolic syndrome, inflammation, and cardiovascular diseases. Here we review recent adipokine research, with particular attention to the roles of adiponectin, leptin, resistin, visfatin, apelin, omentin, and chemerin in such conditions.
Gualillo
Oreste
O
Research Laboratory 4 (Laboratory of Neuro Endocrine Interactions in Rheumatology and Inflammatory Diseases), Santiago University Clinical Hospital, 15706 Santiago de Compostela, Spain.
González-Juanatey
José Ramón
JR
Lago
Francisca
F
D054392:Adipokines; D002318:Cardiovascular Diseases / Q000209:etiology / Q000503:physiopathology*; D002319:Cardiovascular System; D018925:Chemokines; D016207:Cytokines; D006801:Humans; D020738:Leptin; D054409:Nicotinamide Phosphoribosyltransferase; D009765:Obesity / Q000150:complications* / Q000503:physiopathology; D052243:Resistin
D054392:Adipokines; D018925:Chemokines; D016207:Cytokines; D020738:Leptin; D052243:Resistin; D054409:Nicotinamide Phosphoribosyltransferase